血浆脂蛋白 (Plasma lipoprotein) 代谢受各种脂蛋白类别中的特定载脂蛋白 (Apolipoprotein, apo-) 成分的调节和控制。主要载脂蛋白包括 apoE、apoB、apoA-I、apoA-II、apoA-IV、apoC-I、apoC-II 和 apoC-III。特定载脂蛋白通过参与脂质在各种细胞和组织之间的运输和重新分布、通过作为脂质代谢酶的辅助因子或通过维持脂蛋白颗粒的结构来调节脂蛋白代谢。
Plasma lipoprotein metabolism is regulated and controlled by the specific apolipoprotein (apo-) constituents of the various lipoprotein classes. The major apolipoproteins include apoE, apoB, apoA-I, apoA-II, apoA-IV, apoC-I, apoC-II, and apoC-III. Specific apolipoproteins function in the regulation of lipoprotein metabolism through their involvement in the transport and redistribution of lipids among various cells and tissues, through their role as cofactors for enzymes of lipid metabolism, or through their maintenance of the structure of the lipoprotein particles.
Volanesorsen scramble negative control 是 Volanesorsen (MS-Q82600) 的阴性对照形式,序列为 CAUGUTCUTCUGCATGUCAU,而 Volanesorsen (ISIS 304801) 是一种靶向载脂蛋白 CIII (apo-CIII) mRNA 的反义寡核苷酸抑制剂,可降低甘油三酯水平并改善胰岛素抵抗。
Zerlasiran (SLN360) sodium scrambled negative control 是 Zerlasiran sodium (MS-N37318) 的乱序阴性对照,而 Zerlasiran sodium 是一种通过 RNA 干扰靶向并降解编码载脂蛋白 A (ApoA) 的 mRNA 的 siRNA,可用于动脉粥样硬化性心血管疾病及 ApoA 水平升高相关的研究。
© 2026 MolStrong. 保留所有权利。粤ICP备2023004355号
可通过CAS号进行批量搜索,一行一个CAS号